PER-8, a Novel Extended-Spectrum β-Lactamase PER Variant, from an Acinetobacter baumannii Clinical Isolate in Nepal
Tatsuya Tada1, Shovita Shrestha2, Kayo Shimada1
1Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Abstract:
A novel PER-type extended-spectrum β-lactamase, PER-8, was identified in an Acinetobacter baumannii clinical isolate obtained in Nepal. The amino acid sequence of PER-8 has a substitution at position 39 (Gly to Glu) compared with that of PER-7. The kcat/K ratio of PER-8 for aztreonam was lower than that of PER-7, while the kcat/K ratio of PER-8 for imipenem was higher than that of PER-7. The genomic environment surrounding blaPER-8 was intI1 blaPSE-1qacEDI sulI ISCR1-blaPER-8gts sulI orfX on a 100-kb plasmid.
Insights
A new extended-spectrum beta-lactamase, PER-8, was found in Acinetobacter baumannii. This enzyme shows altered activity against specific antibiotics, posing new challenges for treatment.
Area of Science:
- Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Extended-spectrum beta-lactamases (ESBLs) are a significant cause of antibiotic resistance in Gram-negative bacteria.
- Acinetobacter baumannii is an opportunistic pathogen frequently associated with hospital-acquired infections and multidrug resistance.
- The PER-type ESBLs are a class of beta-lactamases that confer resistance to a broad range of beta-lactam antibiotics.
Purpose of the Study:
- To identify and characterize a novel PER-type extended-spectrum beta-lactamase (ESBL) from a clinical isolate of Acinetobacter baumannii.
- To investigate the biochemical properties and substrate specificity of the newly identified PER-8 enzyme.
- To analyze the genetic context and plasmid-mediated dissemination potential of the blaPER-8 gene.
Main Methods:
- Isolation and identification of Acinetobacter baumannii from a clinical sample.
- Molecular characterization of the novel beta-lactamase gene (blaPER-8) using sequencing.
- Biochemical assays to determine kinetic parameters (kcat/K) for various beta-lactam substrates, including aztreonam and imipenem.
- Analysis of the surrounding genetic elements and plasmid structure harboring the blaPER-8 gene.
Main Results:
- A novel PER-type ESBL, designated PER-8, was identified in an Acinetobacter baumannii clinical isolate from Nepal.
- PER-8 differs from PER-7 by a single amino acid substitution (Glycine to Glutamic acid at position 39).
- PER-8 exhibited reduced catalytic efficiency (kcat/K) against aztreonam but increased efficiency against imipenem compared to PER-7.
- The blaPER-8 gene was located within a complex genetic structure (intI1 blaPSE-1 qacEDI sulI ISCR1-blaPER-8 gts sulI orfX) on a 100-kb plasmid.
Conclusions:
- The identification of PER-8 highlights the ongoing evolution of ESBLs in Acinetobacter baumannii.
- The altered substrate profile of PER-8 may impact treatment strategies for infections caused by resistant strains.
- The plasmid-borne nature and complex genetic environment of blaPER-8 suggest potential for horizontal gene transfer and spread.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance
